MOUNT PLEASANT, S.C. (WCSC) — A new, low-maintenance implant device is now available to residents facing incontinence issues, adding freedom back to the lives of patients. A Lowcountry doctor has ...

The EMA has started a review of a regimen based on Pfizer and Astellas' Padcev and MSD's Keytruda that has been described as a game-changer in the treatment of muscle-invasive bladder cancer (MIBC).

Shares of auto parts and accessories retailer AutoZone (NYSE:AZO) fell 1.6% in the afternoon session after the stock's negative momentum continued as the company reported first-quarter earnings that ...

Total Sales Growth: 8.2% increase to $4.6 billion. Earnings Per Share (EPS): Decreased 4.6% to $31.04, impacted by a $98 million LIFO charge. Gross Margin: 51%, down 203 basis points, affected by a ...

Control Resonant is heading our way in 2026, so here's a complete guide on all the latest news and details ahead of Control 2 When you purchase through links on our site, we may earn an affiliate ...

AutoZone remains a defensive, all-weather compounder, now retracing after missing Q1 2026 revenue and EPS estimates. Despite modest 2.4% growth and slower buybacks, AZO's international comps and cash ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

MOUNT PLEASANT, S.C. — A new, low-maintenance implant device is now available to residents facing incontinence issues, adding freedom back to the lives of patients. A South Carolina doctor has become ...